These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 16436141

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. EAACI/GA2LEN/EDF guideline: definition, classification and diagnosis of urticaria.
    Zuberbier T, Bindslev-Jensen C, Canonica W, Grattan CE, Greaves MW, Henz BM, Kapp A, Kozel MM, Maurer M, Merk HF, Schäfer T, Simon D, Vena GA, Wedi B, EAACI/GA2LEN/EDF.
    Allergy; 2006 Mar; 61(3):316-20. PubMed ID: 16436140
    [Abstract] [Full Text] [Related]

  • 3. EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria.
    Zuberbier T, Asero R, Bindslev-Jensen C, Walter Canonica G, Church MK, Giménez-Arnau AM, Grattan CEH, Kapp A, Maurer M, Merk HF, Rogala B, Saini S, Sánchez-Borges M, Schmid-Grendelmeier P, Schünemann H, Staubach P, Vena GA, Wedi B.
    Allergy; 2009 Oct; 64(10):1427-1443. PubMed ID: 19772513
    [Abstract] [Full Text] [Related]

  • 4. Urticaria: current opinions about etiology, diagnosis and therapy.
    Zuberbier T, Maurer M.
    Acta Derm Venereol; 2007 Oct; 87(3):196-205. PubMed ID: 17533484
    [Abstract] [Full Text] [Related]

  • 5. Management of urticaria: a consensus report.
    Zuberbier T, Greaves MW, Juhlin L, Merk H, Stingl G, Henz BM.
    J Investig Dermatol Symp Proc; 2001 Nov; 6(2):128-31. PubMed ID: 11764297
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Treatment of chronic spontaneous urticaria with an inadequate response to H1-antihistamines: an expert opinion.
    Vestergaard C, Toubi E, Maurer M, Triggiani M, Ballmer-Weber B, Marsland A, Ferrer M, Knulst A, Giménez-Arnau A.
    Eur J Dermatol; 2017 Feb 01; 27(1):10-19. PubMed ID: 27882879
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo- controlled treatment with rupatadine 10 and 20 mg.
    Giménez-Arnau A, Izquierdo I, Maurer M.
    J Eur Acad Dermatol Venereol; 2009 Sep 01; 23(9):1088-91. PubMed ID: 19453774
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Urticaria: A comprehensive review: Treatment of chronic urticaria, special populations, and disease outcomes.
    Antia C, Baquerizo K, Korman A, Alikhan A, Bernstein JA.
    J Am Acad Dermatol; 2018 Oct 01; 79(4):617-633. PubMed ID: 30241624
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Levocetirizine in the treatment of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study.
    Nettis E, Colanardi MC, Barra L, Ferrannini A, Vacca A, Tursi A.
    Br J Dermatol; 2006 Mar 01; 154(3):533-8. PubMed ID: 16445787
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.